MDWerks (MDWK) director Richard Blackstone reports 65,325-share equity grant

Rhea-AI Filing Summary

MDWerks, Inc. director Richard Blackstone reported a quarterly equity compensation grant. On 11/13/2025, he acquired 65,325 shares of MDWerks common stock at a stated price of $0.153 per share, classified as an acquisition under his existing arrangements with the company. Following this grant, he beneficially owned 824,011 shares of MDWerks common stock in direct ownership.

The filing explains that these shares were issued on a quarterly basis under an Employment Agreement between Blackstone and MDWerks dated December 3, 2024. The grant was approved by the company’s board of directors and made in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, which governs certain insider compensation-related transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blackstone Richard

(Last) (First) (Middle)

411 WALNUT STREET, SUITE 20125

(Street)

GREEN COVE SPRINGS, FL 32043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MDWerks, Inc. [ MDWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A		65,325(1)	A	$0.153	824,011	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on December 3, 2024. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.

	/s/ Richard Blackstone	12/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MDWerks (MDWK) report for Richard Blackstone?

MDWerks reported that director Richard Blackstone acquired 65,325 shares of common stock on 11/13/2025 as part of his equity compensation.

At what price were the MDWerks (MDWK) shares granted to Richard Blackstone?

The 65,325 shares of MDWerks common stock were reported at a price of $0.153 per share.

How many MDWerks (MDWK) shares does Richard Blackstone own after this transaction?

After the reported grant, Richard Blackstone beneficially owned 824,011 shares of MDWerks common stock in direct ownership.

Why did Richard Blackstone receive these MDWerks (MDWK) shares?

The shares were granted on a quarterly basis under an Employment Agreement between Blackstone and MDWerks dated December 3, 2024.

Did MDWerks’ board approve the share grant to Richard Blackstone?

Yes. The share grant was approved by MDWerks’ board of directors and issued in accordance with Rule 16b-3 under the Exchange Act.

What is Richard Blackstone’s role at MDWerks (MDWK)?

Richard Blackstone is reported as a Director of MDWerks, Inc. in the filing.